GIURATO, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 5.118
AS - Asia 1.201
EU - Europa 772
SA - Sud America 265
Continente sconosciuto - Info sul continente non disponibili 201
AF - Africa 21
OC - Oceania 3
Totale 7.581
Nazione #
US - Stati Uniti d'America 5.045
SG - Singapore 519
IT - Italia 223
BR - Brasile 212
CN - Cina 207
VN - Vietnam 134
RU - Federazione Russa 129
HK - Hong Kong 122
IE - Irlanda 77
BD - Bangladesh 73
FI - Finlandia 65
DE - Germania 62
GB - Regno Unito 50
JP - Giappone 47
FR - Francia 42
CA - Canada 32
UA - Ucraina 32
IN - India 26
MX - Messico 25
SE - Svezia 22
AR - Argentina 21
PL - Polonia 20
NL - Olanda 18
EC - Ecuador 13
ID - Indonesia 11
KR - Corea 11
CO - Colombia 6
ES - Italia 6
PK - Pakistan 6
IQ - Iraq 5
JM - Giamaica 5
MY - Malesia 5
PY - Paraguay 5
RO - Romania 5
ZA - Sudafrica 5
BE - Belgio 4
LT - Lituania 4
PH - Filippine 4
SA - Arabia Saudita 4
TR - Turchia 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AT - Austria 3
CL - Cile 3
EG - Egitto 3
KE - Kenya 3
MA - Marocco 3
TH - Thailandia 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HN - Honduras 2
PE - Perù 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
MM - Myanmar 1
MV - Maldive 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 7.382
Città #
Wilmington 1.095
Houston 940
Woodbridge 639
Singapore 302
San Jose 231
Ashburn 230
Fairfield 188
Chandler 153
Hong Kong 118
Council Bluffs 116
Beijing 99
Seattle 94
Cambridge 76
New York 74
Dublin 65
Los Angeles 63
Santa Clara 61
Helsinki 49
Ann Arbor 47
Rome 46
Medford 43
Ho Chi Minh City 41
The Dalles 40
Tokyo 40
Dallas 31
Hanoi 31
Chicago 27
Milan 25
Menlo Park 24
São Paulo 24
Buffalo 23
Munich 23
North Bergen 21
Lawrence 20
Colorado Springs 19
Moscow 19
Jacksonville 18
Lauterbourg 18
Warsaw 17
Phoenix 15
Frankfurt am Main 13
Orem 13
Redondo Beach 13
London 12
Denver 11
Rio de Janeiro 11
Shanghai 11
Toronto 11
San Diego 10
San Francisco 10
Boardman 9
Chennai 9
Mexico City 9
Palo Alto 9
Salt Lake City 9
Stockholm 9
Atlanta 8
Montreal 8
Sarno 8
Belo Horizonte 7
Dearborn 7
Miami 7
Monmouth Junction 7
Naples 7
Brooklyn 6
Da Nang 6
Lappeenranta 6
Manchester 6
Poplar 6
Seoul 6
Elk Grove Village 5
Florence 5
Lahore 5
Nuremberg 5
Charlotte 4
Cleveland 4
Farmington 4
Guayaquil 4
Haiphong 4
Hangzhou 4
Kuala Lumpur 4
Querétaro 4
Roubaix 4
Suzhou 4
São José dos Campos 4
Thái Nguyên 4
Amsterdam 3
Baghdad 3
Bangkok 3
Birmingham 3
Bắc Ninh 3
Cincinnati 3
Goiânia 3
Gravesend 3
Hưng Yên 3
Iztapalapa 3
Kingston 3
Lucca 3
Misano Adriatico 3
Montes Claros 3
Totale 5.579
Nome #
Risk of contrast induced nephropathy in diabetic patients affected by critical limb ischemia and diabetic foot ulcers treated by percutaneous transluminal angioplasty of lower limbs 480
Limb Salvage in Patients With Diabetes Is Not a Temporary Solution but a Life-Changing Procedure 434
Long term outcomes of diabetic haemodialysis patients with critical limb ischemia and foot ulcer 434
Management of negative pressure wound therapy in the treatment of diabetic foot ulcers 423
Non-healing foot ulcers in diabetic patients: General and local interfering conditions and management options with advanced wound dressings 414
Below-the-ankle arterial disease severely impairs the outcomes of diabetic patients with ischemic foot ulcers 255
Critical limb ischemia: Current challenges and future prospects 244
Rearfoot Transcutaneous Oximetry is a Useful Tool to Highlight Ischemia of the Heel 229
Physician experts in diabetes are natural team leaders for managing diabetic patients with foot complications. A position statement from the Italian diabetic foot study group 226
Endovascular Distal Plantar Vein Arterialization in Dialysis Patients With No-Option Critical Limb Ischemia and Posterior Tibial Artery Occlusion: A Technique for Limb Salvage in a Challenging Patient Subset 209
Limb Salvage in Diabetic Patients With Ischemic Heel Ulcers 208
Recurrence of Critical Limb Ischemia after Endovascular Intervention in Patients with Diabetic Foot Ulcers 208
Diabetes, Lower-Extremity Amputation, and Death. Diabetes Care 2015;38: 1852-1857 203
Peripheral arterial disease in patients with renal-diabetic foot ulcers 201
Osteomyelitis in diabetic foot: A comprehensive overview 198
Effectiveness of Sucrose Octasulfate Dressing in the Treatment of Neuro-Ischaemic Diabetic Foot Heel Ulcers: A Retrospective Single arm Study 188
The Effectiveness of Negative Pressure Therapy in Diabetic Foot Ulcers with Elevated Protease Activity: A Case Series 188
Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot Infection 186
Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers 183
Letter Regarding “The Prostacyclin Analogue Iloprost as an Early Predictor of Successful Revascularization in Diabetic Patients Affected by Critical Limb Ischemia and Foot Ulcers” 163
Attending an integrated nephrology and diabetology outpatient service can improve diabetic kidney disease treatment: a single-center experience 150
Foot Revascularization Avoids Major Amputation in Persons with Diabetes and Ischaemic Foot Ulcers 141
Below-the-ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers 103
Peripheral Blood Mononuclear Cells: A New Frontier in the Management of Patients with Diabetes and No-Option Critical Limb Ischaemia 98
Macrophage Activation and M2 Polarization in Wound Bed of Diabetic Patients Treated by Dermal/Epidermal Substitute Nevelia 97
Early Treatment of Acute Stage 0/1 Diabetic Charcot Foot Can Avoid Major Amputations at One Year 96
Risk Factors for Ulcer Recurrence in Diabetic Patients Managed by an Integrated Foot Care Protocol 96
Hospital Readmission in Patients With Diabetic Foot Ulcers: Prevalence, Causes, and Outcomes 94
Prevalence of Diabetes Mellitus and Clinical Differences in Patients with Severe Osteoporosis and Fragility Fractures 94
Microbiological and Clinical Characteristics of Infected Diabetic Foot Ulcers Managed in a Tertiary Level Diabetic Foot Service 93
Diabetic Foot Osteomyelitis in Patients with and without Peripheral Arterial Disease: Two Different Diseases? 90
The Neuro-Ischaemic Charcot Foot: Prevalence, Characteristics and Severity of Peripheral Arterial Disease in Acute Charcot Neuro-Arthropathy 90
Diabetic Polyneuropathy and Physical Activity in Type 1 Diabetes Mellitus: A Cross-Sectional Study 89
The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration-A Narrative Review 86
Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects 85
Bioactive Glass in a Multi Drug Resistance Osteomyelitis in Diabetic Foot: Case Report 84
Characteristics and outcome for persons with diabetic foot ulcer and no-option critical limb ischemia 80
Effectiveness of fast-track pathway for diabetic foot ulcerations 80
Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems 71
Prevalence, clinical aspects and outcomes in a large cohort of persons with diabetic foot disease: Comparison between neuropathic and ischemic ulcers 70
Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers 65
The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)—Rationale and Meta-Analysis of Observational Studies 58
Response to the letter of Tariq and colleagues on the paper "below‑the‑ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers" 56
Management of diabetic persons with foot ulceration during COVID-19 health care emergency: Effectiveness of a new triage pathway 52
Incidence and causes of major amputation in patients with diabetic foot ulcers: data from a retrospective study 51
Correction to: Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects 43
Use of Nevelia Dermal-Epidermal Regenerative Template in the Management of Ischemic Diabetic Foot Postsurgical Wounds 39
Diabetic Foot Infections: The Diagnostic Challenges 26
Predictive factors of major amputation in patients with diabetic foot ulcers treated by peripheral blood mononuclear cells 16
Metabolic and renal effects of combined SGLT-2 inhibitors and GLP1-R agonists therapy in type 2 diabetes: a real-world analysis across DKD and non-DKD patients 14
Totale 7.581
Categoria #
all - tutte 23.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.774


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022205 0 0 26 2 2 24 15 7 11 19 21 78
2022/2023357 20 46 6 43 51 70 37 26 35 1 15 7
2023/2024138 11 3 20 2 9 27 25 4 8 1 5 23
2024/2025862 30 142 73 49 60 121 56 46 59 79 74 73
2025/20262.310 112 201 257 244 232 79 311 198 219 175 145 137
2026/2027411 135 184 92 0 0 0 0 0 0 0 0 0
Totale 7.581